Overview

A Trial of AXS-05 in Patients With Major Depressive Disorder

Status:
Completed
Trial end date:
2019-12-05
Target enrollment:
Participant gender:
Summary
A Phase 3, randomized, double-blind, placebo-controlled, multicenter trial of AXS-05 in patients with major depressive disorder (MDD).
Phase:
Phase 3
Details
Lead Sponsor:
Axsome Therapeutics, Inc.
Treatments:
Dextromethorphan